APA (7th ed.) Citation

Gillessen, S. K., Plütschow, A., Fuchs, M., Markova, J., Greil, R., Topp, M. S., . . . von Tresckow, B. (2021). Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: Long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14). The lancet. Haematology, 8(4), . https://doi.org/10.1016/S2352-3026(21)00029-6

Chicago Style (17th ed.) Citation

Gillessen, Sarah Kathrin, et al. "Intensified Treatment of Patients with Early Stage, Unfavourable Hodgkin Lymphoma: Long-term Follow-up of a Randomised, International Phase 3 Trial of the German Hodgkin Study Group (GHSG HD14)." The Lancet. Haematology 8, no. 4 (2021). https://doi.org/10.1016/S2352-3026(21)00029-6.

MLA (9th ed.) Citation

Gillessen, Sarah Kathrin, et al. "Intensified Treatment of Patients with Early Stage, Unfavourable Hodgkin Lymphoma: Long-term Follow-up of a Randomised, International Phase 3 Trial of the German Hodgkin Study Group (GHSG HD14)." The Lancet. Haematology, vol. 8, no. 4, 2021, https://doi.org/10.1016/S2352-3026(21)00029-6.